Cargando…

Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities

PURPOSE: Due to complex medical profiles, adults with neurodevelopmental disabilities (NDDs) may have a heightened risk for early development of chronic kidney disease (CKD) and accelerated CKD progression to advanced stages and kidney failure. The purpose of this study was to estimate the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitney, Daniel G, Schmidt, Mary, Bell, Sarah, Morgenstern, Hal, Hirth, Richard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051893/
https://www.ncbi.nlm.nih.gov/pubmed/32161503
http://dx.doi.org/10.2147/CLEP.S242264
_version_ 1783502753169932288
author Whitney, Daniel G
Schmidt, Mary
Bell, Sarah
Morgenstern, Hal
Hirth, Richard A
author_facet Whitney, Daniel G
Schmidt, Mary
Bell, Sarah
Morgenstern, Hal
Hirth, Richard A
author_sort Whitney, Daniel G
collection PubMed
description PURPOSE: Due to complex medical profiles, adults with neurodevelopmental disabilities (NDDs) may have a heightened risk for early development of chronic kidney disease (CKD) and accelerated CKD progression to advanced stages and kidney failure. The purpose of this study was to estimate the incidence rate of advanced CKD for adults with NDDs and compare the incidence rate to adults without NDDs. PATIENTS AND METHODS: Data were used from the Optum Clinformatics(®) Data Mart to conduct this retrospective cohort study. The calendar year 2013 was used to identify eligible participants: individuals ≥18 years of age and without advanced CKD. Participants were followed from 01/01/2014 to advanced CKD, loss to follow-up, death, or end of the study period (12/31/2017), whichever came first. Diagnostic, procedure, and diagnosis-related group codes identified NDDs (intellectual disabilities, cerebral palsy, autism spectrum disorders), incident cases of advanced CKD (CKD stages 4+), diabetes, cardiovascular diseases, and hypertension present in the year 2013. Crude incidence rates (IR) of advanced CKD and IR ratios (IRR), comparing adults with vs without NDDs (with 95% CI) were estimated. Then, Cox regression estimated the hazard ratio (HR and 95% CI) for advanced CKD, comparing adults with NDDs to adults without NDDs while adjusting for covariates. RESULTS: Adults with NDDs (n=33,561) had greater crude IR of advanced CKD (IRR=1.32; 95% CI=1.24–1.42) compared to adults without NDDs (n=6.5M). The elevated rate of advanced CKD among adults with NDDs increased after adjusting for demographics (HR=2.19; 95% CI=2.04–2.34) and remained elevated with further adjustment for hypertension and diabetes (HR=2.01; 95% CI=1.87–2.15) plus cardiovascular disease (HR=1.84; 95% CI=1.72–1.97). Stratified analyses showed that the risk of advanced CKD was greater for all NDD subgroups. CONCLUSION: Study findings suggest that adults with NDDs have a greater risk of advanced CKD than do adults without NDDs, and that difference is not explained by covariates used in our analysis.
format Online
Article
Text
id pubmed-7051893
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70518932020-03-11 Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities Whitney, Daniel G Schmidt, Mary Bell, Sarah Morgenstern, Hal Hirth, Richard A Clin Epidemiol Original Research PURPOSE: Due to complex medical profiles, adults with neurodevelopmental disabilities (NDDs) may have a heightened risk for early development of chronic kidney disease (CKD) and accelerated CKD progression to advanced stages and kidney failure. The purpose of this study was to estimate the incidence rate of advanced CKD for adults with NDDs and compare the incidence rate to adults without NDDs. PATIENTS AND METHODS: Data were used from the Optum Clinformatics(®) Data Mart to conduct this retrospective cohort study. The calendar year 2013 was used to identify eligible participants: individuals ≥18 years of age and without advanced CKD. Participants were followed from 01/01/2014 to advanced CKD, loss to follow-up, death, or end of the study period (12/31/2017), whichever came first. Diagnostic, procedure, and diagnosis-related group codes identified NDDs (intellectual disabilities, cerebral palsy, autism spectrum disorders), incident cases of advanced CKD (CKD stages 4+), diabetes, cardiovascular diseases, and hypertension present in the year 2013. Crude incidence rates (IR) of advanced CKD and IR ratios (IRR), comparing adults with vs without NDDs (with 95% CI) were estimated. Then, Cox regression estimated the hazard ratio (HR and 95% CI) for advanced CKD, comparing adults with NDDs to adults without NDDs while adjusting for covariates. RESULTS: Adults with NDDs (n=33,561) had greater crude IR of advanced CKD (IRR=1.32; 95% CI=1.24–1.42) compared to adults without NDDs (n=6.5M). The elevated rate of advanced CKD among adults with NDDs increased after adjusting for demographics (HR=2.19; 95% CI=2.04–2.34) and remained elevated with further adjustment for hypertension and diabetes (HR=2.01; 95% CI=1.87–2.15) plus cardiovascular disease (HR=1.84; 95% CI=1.72–1.97). Stratified analyses showed that the risk of advanced CKD was greater for all NDD subgroups. CONCLUSION: Study findings suggest that adults with NDDs have a greater risk of advanced CKD than do adults without NDDs, and that difference is not explained by covariates used in our analysis. Dove 2020-02-27 /pmc/articles/PMC7051893/ /pubmed/32161503 http://dx.doi.org/10.2147/CLEP.S242264 Text en © 2020 Whitney et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Whitney, Daniel G
Schmidt, Mary
Bell, Sarah
Morgenstern, Hal
Hirth, Richard A
Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title_full Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title_fullStr Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title_full_unstemmed Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title_short Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
title_sort incidence rate of advanced chronic kidney disease among privately insured adults with neurodevelopmental disabilities
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051893/
https://www.ncbi.nlm.nih.gov/pubmed/32161503
http://dx.doi.org/10.2147/CLEP.S242264
work_keys_str_mv AT whitneydanielg incidencerateofadvancedchronickidneydiseaseamongprivatelyinsuredadultswithneurodevelopmentaldisabilities
AT schmidtmary incidencerateofadvancedchronickidneydiseaseamongprivatelyinsuredadultswithneurodevelopmentaldisabilities
AT bellsarah incidencerateofadvancedchronickidneydiseaseamongprivatelyinsuredadultswithneurodevelopmentaldisabilities
AT morgensternhal incidencerateofadvancedchronickidneydiseaseamongprivatelyinsuredadultswithneurodevelopmentaldisabilities
AT hirthricharda incidencerateofadvancedchronickidneydiseaseamongprivatelyinsuredadultswithneurodevelopmentaldisabilities